India News | Over 200 Drugs Identified to Be Not of Standard Quality in CDSCO List for November

Get latest articles and stories on India at LatestLY. The Central Drugs Standard Control Organisation (CDSCO) on Friday released the list of Not of Standard Quality (NSQ) and Spurious drugs for November 2025 on its portal, according to a release.

Logo of Central Drugs Standard Control Organisation. (Photo/CDSCO/OfficialSite)

New Delhi [India], December 19 (ANI): The Central Drugs Standard Control Organisation (CDSCO) found 64 drug samples to be Not of Standard Quality (NSQ) in November, and State Drugs Testing Laboratories have identified 141 drug samples as NSQ, a release said on Friday.

The list of Not of Standard Quality (NSQ) drugs is displayed on the CDSCO portal every month.

Also Read | Maharashtra Local Body Elections 2025: Voting for 24 Nagar Parishads and Panchayats to Be Held Tomorrow, Counting of Votes on December 21.

"As per routine regulatory surveillance activity, the list of Not of Standard Quality (NSQ) and Spurious drugs are being displayed on the CDSCO portal on a monthly basis. For the month of November 2025, Central Drugs Laboratories have identified 64 Drug Samples to be Not of Standard Quality (NSQ) and State Drugs Testing Laboratories have identified 141 Drug Samples as Not of Standard Quality (NSQ). Identification of drug samples as NSQ is done based on failure of the drug sample in one or the specified quality parameters. The failure is specific to the drug products of the batch tested by the Government. Laboratory and it does not warrant any concerns on the other drug products available in the market," the release stated.

Further, two drugs samples from North North Zone, Ghaziabad, have been identified as spurious drugs in the month of November, which were manufactured by unauthorised manufacturers using a brand name owned by another company, the release stated.

Also Read | PM Narendra Modi to Inaugurate New Terminal Building of Guwahati Airport, Unveil INR 15,600-Crore Development Projects in Assam.

This action of identifying NSQ and spurious medicines is taken regularly in collaboration with state regulators to ensure that these drugs are identified and removed from the market. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)

Share Now

Share Now